BioLife4D Corporation (SAVU)

BioLife4D will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.20 - $7.20
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 32.31M
Revenue (ttm) n/a
Net Income (ttm) -1.96M
Shares Out 5.21M
EPS (ttm) -0.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About SAVU

BioLife4D Corporation is a pioneering biotech company that plans to leverage current advances in life sciences and cardiac tissue engineering to build human hearts suitable for implantation – potentially lifesaving technology that ultimately gives patients the gift of time. We are committed to perfecting the technology to make viable organ replacement an accessible and affordable reality, as well as mini-hearts for cardiotoxicity testing. We believe that our groundbreaking approach converges recent breakthroughs in regenerative medicine, adult ... [Read more]

Industry Health Care
Sector Biotechnology
Founded 2016
Employees 7
Stock Exchange NASDAQ
Ticker Symbol SAVU
Full Company Profile

Financial Performance

Financial Statements


BIOLIFE4D IPO Registration Document (S-1)

BIOLIFE4D has filed to go public with an IPO on the NASDAQ.

2 years ago - SEC